Skip to content
Gene2Rx home

Try

Loading…

Search couldn't load. Check your connection and try again, or use the medication lookup.

No pages match .

The medication lookup checks any medication by name, including ones without their own page.

Get my report

23andMe Pharmacogenetics: How to Get a Drug Response Report From Your Existing Data

You already paid to read your DNA. Here is how to turn your 23andMe raw data into a guideline-based report on 120 medications, what a genotyping chip reliably shows, and the one thing it cannot.

Reviewed by the Gene2Rx team. Updated 2026-05-28.

Looking for a different angle? See exactly what your drug response report shows, drug by drug

23andMe gives you raw genetic data: the genotype calls from the chip it ran on your saliva. What it does not give you is a guideline-based report on how those genes affect your medications. That is what Gene2Rx adds. Upload your 23andMe raw data file and Gene2Rx turns it into a pharmacogenetics report covering 120 medications, built on the same CPIC and FDA guidelines clinicians use. It runs in minutes, costs $5 for a starter report or $50 for the full report, needs no doctor's order, and never expires, because your DNA does not change. You already paid to have your DNA read; this unlocks the part of it that affects prescriptions.

Important: A pharmacogenetic report from your 23andMe data is informational and does not replace medical advice. Never change or stop a medication based on genetic results alone. Always discuss the report with your healthcare provider before making any treatment change.

$5 to turn 23andMe data you already have into a starter pharmacogenetic report; $50 for the full 120-medication version

What your 23andMe data can and cannot do

Your 23andMe chip already captured the right variants

23andMe's genotyping chip reads hundreds of thousands of positions, including many of the pharmacogenetic variants used in clinical testing: the markers for CYP2D6, CYP2C19, CYP2C9, SLCO1B1, VKORC1, DPYD, and more are sitting in your raw data file. 23andMe simply does not interpret most of them for drug response. The genotypes are there; what is missing is the analysis that turns them into per-medication guidance.

What Gene2Rx produces from that file

Gene2Rx reads your raw data, calls your metabolizer phenotype for each pharmacogene (poor, intermediate, normal, rapid, or ultrarapid), and maps each phenotype to specific recommendations for 120 medications, with every recommendation traceable to its CPIC or FDA guideline. The report spans psychiatry (antidepressants, antipsychotics, ADHD medications), cardiology (clopidogrel, warfarin, statins, metoprolol), pain (codeine, tramadol), chemotherapy (capecitabine, fluorouracil), transplant, and gastrointestinal drugs. It is delivered in minutes, no new sample and no prescriber required.

What a genotyping chip cannot show

It is worth being clear about the limits. A 23andMe chip is a consumer product built for ancestry and traits, not a clinical-grade assay, and the raw data download is labeled as not for medical use. It also reads only the specific positions printed on the chip, so it does not detect structural variants such as gene duplications and deletions. That matters most for CYP2D6,[1] where an extra gene copy can make someone an ultrarapid metabolizer and a deleted copy can leave almost no enzyme. For most prescribing questions your 23andMe data is a strong, low-cost starting point; for a high-stakes, one-time decision such as chemotherapy dosing, a clinician may still confirm a key result with a clinical-grade test.

23andMe's own pharmacogenetics report is deliberately limited

23andMe does include an FDA-authorized pharmacogenetics report, but it is narrow by design: it reads a small, fixed set of variants in a few genes, is framed as wellness information, and explicitly tells you to confirm anything actionable with a clinical test. It does not give you guideline-based recommendations across your medication list. Gene2Rx reads far more pharmacogenetic variants from the same raw file and reports against 120 medications using CPIC and FDA dosing guidance.

A fraction of the cost of a clinical PGx test, and it lasts for life

Clinical pharmacogenetic tests like GeneSight run from a few hundred to a few thousand dollars, need a new DNA sample, and require a provider order. Because you already have 23andMe data, none of that applies: a Gene2Rx report is $5 for the starter tier, $35 for a psychiatric report, or $50 for the full 120-medication report, with no lab work to repeat. Your pharmacogenetic profile does not change over time, so a single report is a reference you will use for decades of prescribing decisions.

The genotypes are already sitting in your 23andMe file. What is missing is the interpretation.

How your genetics can play a role

These are the main genes Gene2Rx reads out of your 23andMe data and what each one affects. The biology is the same no matter which data source you start from; what 23andMe provides is the raw genotype at these positions.

GeneWhat it affects
CYP2D6
CYP2C19
CYP2C9 and VKORC1
SLCO1B1
DPYD
TPMT and NUDT15

Your 23andMe raw data contains the genotypes for all of these genes; the only thing standing between that and actionable guidance is interpretation. Gene2Rx translates your genotypes into metabolizer phenotypes for each gene, then maps those phenotypes to specific medication recommendations anchored to CPIC[1] and FDA[9] guidelines, so the output reads the same way a clinical pharmacogenetic report would.

Already have your 23andMe data? Turn it into a report covering 120 medications.

Gene2Rx reads the pharmacogenes already sitting in your 23andMe raw data and tells you what CPIC and FDA guidelines say about the prescriptions you are on now.

When to consider pharmacogenetic testing

If you already have 23andMe data, there is little reason to wait: the data exists and the starter report is $5. It is most valuable if you are starting or already taking a medication with pharmacogenetic guidelines, if you have had side effects or poor response in the past, or if you simply want the information on file for future prescribing. Because your genotype never changes, one report serves you for life.

What you can do next

  1. Download your 23andMe raw data: sign in at 23andMe.com, then go to Settings, 23andMe Data, and Download Raw Data (a .txt file).
  2. Upload the file to gene2rx.com. The analysis finishes in a few minutes. The starter report is $5; the full 120-medication report is $50.
  3. Review your metabolizer status for each pharmacogene and the medications flagged for you.
  4. Save the report and share the relevant section with your doctor or pharmacist before any new prescription, and ask whether any high-stakes result is worth confirming with a clinical-grade test.

Frequently asked questions

Does 23andMe already tell me how I respond to drugs?

Only narrowly. 23andMe's FDA-authorized pharmacogenetics report reads a small fixed set of variants, is framed as wellness information, and recommends clinical confirmation before acting. Gene2Rx reads far more pharmacogenetic variants from the same raw data file and reports against 120 medications with CPIC and FDA guideline-based recommendations.

Is 23andMe data accurate enough for pharmacogenetics?

For the common variants, yes. 23andMe's genotyping chip reliably captures the pharmacogenetic markers that drive the majority of actionable recommendations. Two caveats are worth knowing: it is a consumer-grade product whose raw data is labeled not for medical use rather than a clinical-grade assay, and like all genotyping chips it does not detect structural variants such as CYP2D6 gene duplications or deletions. For the most complete picture, whole genome sequencing resolves more: Gene2Rx accepts it too, and its CYP2D6 Structural Analysis add-on measures CYP2D6 duplications and deletions from the BAM or CRAM file. A clinician may also confirm a high-stakes result with a clinical-grade test.

Can I use 23andMe data from years ago?

Yes. Your DNA does not change, so any chip version works. Older versions cover slightly fewer variants, but the core pharmacogenetic markers have been included since early 23andMe chips.

What if I have AncestryDNA or whole genome data instead?

Those work too. Gene2Rx accepts 23andMe, AncestryDNA, and MyHeritage raw data, plus VCF files from whole genome sequencing. The process is the same: download your raw data and upload it. WGS and VCF uploads carry a $20 surcharge because they take more processing.

References

  1. Clinical Pharmacogenetics Implementation Consortium (CPIC). CPIC Guidelines. cpicpgx.org
  2. CPIC. CPIC Guideline for Opioids (Codeine, Tramadol) and CYP2D6, OPRM1, and COMT (2021). cpicpgx.org
  3. CPIC. CPIC Guideline for SSRI and SNRI Antidepressants and CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A (2023). cpicpgx.org
  4. CPIC. CPIC Guideline for Clopidogrel and CYP2C19 (2022). cpicpgx.org
  5. CPIC. CPIC Guideline for Pharmacogenetics-Guided Warfarin Dosing (CYP2C9, VKORC1, CYP4F2) (2017). cpicpgx.org
  6. CPIC. CPIC Guideline for Statins and SLCO1B1, ABCG2, and CYP2C9 (2022). cpicpgx.org
  7. CPIC. CPIC Guideline for Fluoropyrimidines and DPYD (2017). cpicpgx.org
  8. CPIC. CPIC: TPMT/NUDT15 thiopurine guideline, 2025 update (2026). pmc.ncbi.nlm.nih.gov
  9. U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov

You already have the data. Turn your 23andMe file into a full medication report.

Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your medication. Never stop or change a medication without medical supervision.